BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27784519)

  • 1. Fowler's Solution and the Evolution of the Use of Arsenic in Modern Medicine.
    Ho D; Lowenstein EJ
    Skinmed; 2016; 14(4):287-289. PubMed ID: 27784519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: the history of arsenic trioxide in cancer therapy.
    Antman KH
    Oncologist; 2001; 6 Suppl 2():1-2. PubMed ID: 11331433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How acute promyelocytic leukaemia revived arsenic.
    Zhu J; Chen Z; Lallemand-Breitenbach V; de Thé H
    Nat Rev Cancer; 2002 Sep; 2(9):705-13. PubMed ID: 12209159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide in the management of acute promyelocytic leukaemia.
    Mathews V; Chandy M; Srivastava A
    Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute promyelocytic leukemia with arsenic trioxide.
    Conrad ME
    N Engl J Med; 1999 Apr; 340(13):1043-5. PubMed ID: 10189286
    [No Abstract]   [Full Text] [Related]  

  • 6. History of the development of arsenic derivatives in cancer therapy.
    Waxman S; Anderson KC
    Oncologist; 2001; 6 Suppl 2():3-10. PubMed ID: 11331434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic: a beneficial therapeutic poison - a historical overview.
    Thomas X; Troncy J
    Adler Mus Bull; 2009 Jun; 35(1):3-13. PubMed ID: 20052806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution.
    Tinwell H; Stephens SC; Ashby J
    Environ Health Perspect; 1991 Nov; 95():205-10. PubMed ID: 1821373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fowler's solution as an etiologic agent in cirrhosis.
    FRANKLIN M; BEAN WB; HARDIN RC
    Am J Med Sci; 1950 Jun; 219(6):589-96. PubMed ID: 15419170
    [No Abstract]   [Full Text] [Related]  

  • 10. The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma.
    Kalmadi SR; Hussein MA
    Acta Haematol; 2006; 116(1):1-7. PubMed ID: 16809883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medicinal arsenic poisoning with Fowler's solution].
    GATTNER M
    Z Gesamte Inn Med; 1953 Mar; 8(5):233-6. PubMed ID: 13078877
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic investigations in psoriasis. III. Oral triamcinolone associated with potassium arsenite (Fowler's solution)].
    FERNANDEZ JM; VACCARO A; AGUERO H
    Arch Argent Dermatol; 1961 Dec; 11():357-67. PubMed ID: 13892409
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
    Perreault S; Moeller J; Patel K; Eyler R; Pham T; Russell K; Podoltsev N
    J Oncol Pharm Pract; 2016 Aug; 22(4):646-51. PubMed ID: 25972392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide in acute promyelocytic leukemia: potion not poison.
    Powell BL
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1317-9. PubMed ID: 21929304
    [No Abstract]   [Full Text] [Related]  

  • 15. Fowler's solution for treatment of recurrent intraurethral condyloma acuminata.
    Harrison RH
    Urology; 1974 Jul; 4(1):121. PubMed ID: 21323002
    [No Abstract]   [Full Text] [Related]  

  • 16. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
    Wu J; Shao Y; Liu J; Chen G; Ho PC
    J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
    Sui M; Zhang Z; Zhou J
    Chin Med J (Engl); 2014; 127(19):3503-6. PubMed ID: 25269921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poisoning the Devil.
    Chen Z; Chen SJ
    Cell; 2017 Feb; 168(4):556-560. PubMed ID: 28187275
    [No Abstract]   [Full Text] [Related]  

  • 19. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
    Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
    Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].
    Lengfelder E; Schultheis B; Büchner T; Hehlmann R
    Dtsch Med Wochenschr; 2007 Feb; 132(7):330-6. PubMed ID: 17286223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.